Join
Live feed
·
PRReleasevia Quantisnow
SOPHiA GENETICS SA logo

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

ByQuantisnow·Wall Street's wire, on your screen.
SOPH· SOPHiA GENETICS SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SOPH (SOPHiA GENETICS SA) and more on Quantisnow.